Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $910.5M | $444.7M | $397.6M | $404.1M | $335.7M | $269.7M | $309.0M | $290.2M | $699.1M | $596.5M | $500.9M | $408.5M | $328.1M | $233.5M | $160.2M |
| Research & development | $56.1M | $44.8M | $36.7M | $29.6M | $24.9M | $25.2M | $26.0M | $18.5M | $78.1M | $45.9M | $50.1M | $40.1M | $32.7M | $23.6M | $16.9M |
| Operating income | $114.1M | $51.3M | $124.2M | $142.3M | $120.6M | $76.4M | $96.5M | $82.4M | −$64.3M | −$26.6M | −$44.8M | −$50.7M | −$44.7M | −$27.4M | −$33.8M |
| EBITDAderived | $174.4M | $70.2M | $140.9M | $154.9M | $136.1M | $90.5M | $113.2M | $96.8M | $81.2M | $79.0M | $42.2M | $13.8M | $10.8M | $9.5M | −$1.2M |
| Net income | $12.9M | $13.7M | $145.7M | $92.1M | $152.7M | −$250.0M | −$146.0M | −$162.0M | −$172.0M | −$124.5M | −$107.6M | −$84.5M | −$111.3M | −$32.7M | $23.6M |
| Basic EPSper diluted share | $0.10 | $0.11 | $1.12 | $0.75 | $1.46 | -$3.04 | -$1.81 | -$2.02 | -$2.17 | -$1.58 | -$1.35 | -$0.99 | -$3.05 | -$14.07 | -$2.63 |
| Diluted EPSper diluted share | $0.09 | $0.10 | $1.09 | $0.71 | $1.28 | -$3.04 | -$1.81 | -$2.02 | -$2.17 | -$1.58 | -$1.35 | -$0.99 | -$3.05 | -$14.07 | -$2.63 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 12, 2026Form 4 | TOWNSEND CHARLES CDirector | BuyCommon Stock | 158.6K | $4.57 | $724.8K | 418.7K |
| Mar 11, 2026Form 4 | TOWNSEND CHARLES CDirector | BuyCommon Stock | 91.4K | $4.54 | $415.0K | 260.1K |
| Dec 12, 2025Form 4 | THORNE OAKLEIGHExecutive Chair | BuyCommon Stock | 150.0K | $5.35 | $802.5K | 954.1K |
| Dec 12, 2025Form 4 | THORNE OAKLEIGHExecutive Chair | BuyCommon Stock | 20.0K | $5.24 | $104.8K | 804.1K |
| Nov 19, 2025Form 4 | TOWNSEND CHARLES CDirector | BuyCommon Stock | 31.2K | $7.17 | $223.9K | 168.7K |